TARA – protara therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Protara Therapeutics, Inc. (NASDAQ: TARA) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $22.00 price target on the stock.
Protara Therapeutics, Inc. (NASDAQ: TARA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
Protara Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update [Yahoo! Finance]
Protara Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
Protara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Form SCHEDULE 13G/A Protara Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
Form S-8 Protara Therapeutics,
Form 10-K Protara Therapeutics, For: Dec 31
Form 8-K Protara Therapeutics, For: Mar 05
Form SCHEDULE 13G/A Protara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.